Intensive Virtual Treatment With Remote Abstinence Monitoring for Alcohol Use Disorder (NCT05722483) | Clinical Trial Compass
CompletedNot Applicable
Intensive Virtual Treatment With Remote Abstinence Monitoring for Alcohol Use Disorder
Canada63 participantsStarted 2023-01-30
Plain-language summary
This single-arm pilot study will recruit participants with moderate to severe alcohol use disorder for a 4-week virtual intensive outpatient program (IOP). The program aims to replicate the structure and abstinence monitoring of a residential treatment program although the program is delivered entirely virtually.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. ≥ 18 years of age
✓. Able to communicate and provide informed consent in English
✓. Diagnosis of moderate to severe AUD, based on the Structured Clinical Interview for DSM-5, Research Version (SCID-5-RV)
✓. Risky alcohol consumption, defined as \> 10 drinks per week for females and \> 15 drinks for males on average during the 60 days prior to the eligibility assessment.
✓. Motivated to abstain from alcohol for the month-long treatment period (longer-term harm reduction goals are permitted)
✓. Access to a private location from which to participate in the program for the duration of the study.
✓. Able and motivated to complete all aspects of the program, including attending all virtual intensive outpatient program sessions (this includes being available for group and individual sessions throughout the day on weekdays) and completing multiple daily breathalyzer readings throughout the entire program. Individuals planning to be out of the province during the virtual intensive outpatient program will not be permitted to enroll.
✓. Enrolled in the Ontario Health Insurance Plan (OHIP)
Exclusion criteria
✕. Severe medical or psychiatric comorbidity that would prevent safe participation in the study
✕. Active and severe suicidal ideation at time of eligibility assessment or suicide attempt within the past month.
What they're measuring
1
Retention in treatment
Timeframe: 28 Days
2
Satisfaction with treatment as assessed by the Client Satisfaction Questionnaire-8 (CSQ-8)
. Diagnosis of opioid use disorder or sedative use disorder within the past year based on the SCID-5 (other concurrent substance use disorders such as cannabis use disorder will not be exclusionary)
✕. History of alcohol withdrawal delirium
✕. Currently pregnant, breastfeeding, or intending to become pregnant or breastfeed during the study.
✕. Enrollment in another study that conflicts with the procedures or scientific integrity of this study
✕. Individuals planning to be out of the province during the virtual intensive outpatient program will not be permitted to enroll.